Track Advanced Biomed Common Stock's receivables ($3K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Advanced Biomed Common Stock (ADVB) currently reports a receivables of $3K as of March 2026. That compares with $6.5K in the prior-year period — down 53.3% year over year. Use the charts on this page to explore Advanced Biomed Common Stock's receivables history and peer comparisons.
Advanced Biomed Common Stock's receivables decreased from $6.5K to $3K — a 53.3% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Advanced Biomed Common Stock reported $3K in receivables as of March 2026. That compares with $6.5K in the prior-year period — down 53.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $3K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Advanced Biomed Common Stock, and consider following ADVB for alerts when major investors trade the stock.